Company Overview

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

  • Name

    Humana Inc.

  • CEO

    Mr. James A. Rechtin M.B.A.

  • Website

    www.humana.com

  • Sector

    Health Care Providers and Services

  • Year Founded

    1961

Profile

  • Market Cap

    $38.72B

  • EV

    $46.54B

  • Shares Out

    120.4M

  • Revenue

    $112.04B

  • Employees

    67,600

Margins

  • Gross

    15.48%

  • EBITDA

    3.8%

  • Operating

    3.47%

  • Pre-Tax

    2.11%

  • Net

    1.53%

  • FCF

    -4.51%

Returns (5Yr Avg)

  • ROA

    7.44%

  • ROTA

    21.87%

  • ROE

    20.36%

  • ROCE

    18.15%

  • ROIC

    20.66%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $393.73

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $5,501M

  • Net Debt

    $7,769M

  • Debt/Equity

    0.79

  • EBIT/Interest

    6.63

Growth (CAGR)

  • Rev 3Yr

    11.67%

  • Rev 5Yr

    13.03%

  • Rev 10Yr

    9.69%

  • Dil EPS 3Yr

    -9.55%

  • Dil EPS 5Yr

    -5.23%

  • Dil EPS 10Yr

    7.7%

  • Rev Fwd 2Yr

    4.53%

  • EBITDA Fwd 2Yr

    -9.94%

  • EPS Fwd 2Yr

    -12.29%

  • EPS LT Growth Est

    4.84%

Dividends

  • Yield

  • Payout

    25.21%

  • DPS

    $3.54

  • DPS Growth 3Yr

    10.13%

  • DPS Growth 5Yr

    11.01%

  • DPS Growth 10Yr

    12.5%

  • DPS Growth Fwd 2Yr

    8.18%

NYSE:HUM